Two independent analytical testing pathways provide an additional layer of review. Submitted batch samples may be evaluated through Finnrick-coordinated independent laboratory testing and through Janoshik analytical testing.
Finnrick describes a standard process in which submitted samples are analyzed by independent partner laboratories, including chromatographic comparison against a reference for the expected product.
A separate analytical pathway that may be selected for batch or sample characterization. The analyses and conclusions displayed with a future report will be limited to the methods actually ordered and performed.
HPLC separates components as a sample moves through a chromatographic system. The resulting chromatogram can evaluate relative composition and quantify chromatographic purity under the analytical method used.
For peptide testing, it can reveal a dominant peptide peak and additional detectable components or related impurities. A reported purity describes the proportion of the principal peak under that method and those testing conditions.
Identity verification
Purity and identity answer different questions. Identity testing evaluates whether a sample’s analytical characteristics are consistent with the expected compound or reference, rather than relying on a purity percentage alone.
LC-MS / mass spectrometry
Where included in the selected test panel, liquid chromatography–mass spectrometry adds mass-based detection. Depending on the method, it can support identification or detect certain peptide-related contaminants and degradation products.
Quantity verification
Where quantitative testing is performed, measured material can be compared with the expected labeled quantity. Quantity, identity, purity, sterility, heavy metals, and microbial analyses remain distinct result categories and appear only when performed.